136 related articles for article (PubMed ID: 38564213)
1. A Systematic Review of Oral Pre-exposure Prophylaxis HIV Adherence Interventions.
Haines M; Vandyk A; Skidmore B; Orser L; O'Byrne P
J Assoc Nurses AIDS Care; 2024 Jul-Aug 01; 35(4):309-324. PubMed ID: 38564213
[TBL] [Abstract][Full Text] [Related]
2. Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of "Life-Steps for PrEP".
Mayer KH; Safren SA; Elsesser SA; Psaros C; Tinsley JP; Marzinke M; Clarke W; Hendrix C; Wade Taylor S; Haberer J; Mimiaga MJ
AIDS Behav; 2017 May; 21(5):1350-1360. PubMed ID: 27848089
[TBL] [Abstract][Full Text] [Related]
3. Study on Pre-Exposure Prophylaxis Regimens among Men Who Have Sex with Men: A Prospective Cohort Study.
Wu D; Tao H; Dai J; Liang H; Huang A; Zhong X
Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31818006
[No Abstract] [Full Text] [Related]
4. The Effect of Depression on Adherence to HIV Pre-exposure Prophylaxis Among High-Risk South African Women in HPTN 067/ADAPT.
Velloza J; Heffron R; Amico KR; Rowhani-Rahbar A; Hughes JP; Li M; Dye BJ; Celum C; Bekker LG; Grant RM;
AIDS Behav; 2020 Jul; 24(7):2178-2187. PubMed ID: 31955360
[TBL] [Abstract][Full Text] [Related]
5. Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.
Marcus JL; Buisker T; Horvath T; Amico KR; Fuchs JD; Buchbinder SP; Grant RM; Liu AY
HIV Med; 2014 Aug; 15(7):385-95. PubMed ID: 24580813
[TBL] [Abstract][Full Text] [Related]
6. Adaptive HIV pre-exposure prophylaxis adherence interventions for young South African women: Study protocol for a sequential multiple assignment randomized trial.
Velloza J; Poovan N; Ndlovu N; Khoza N; Morton JF; Omony J; Mkwanazi E; Grabow C; Donnell D; Munthali R; Baeten JM; Hosek S; Celum C; Delany-Moretlwe S
PLoS One; 2022; 17(4):e0266665. PubMed ID: 35417485
[TBL] [Abstract][Full Text] [Related]
7. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
Songtaweesin WN; Kawichai S; Phanuphak N; Cressey TR; Wongharn P; Saisaengjan C; Chinbunchorn T; Janyam S; Linjongrat D; Puthanakit T;
J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
[TBL] [Abstract][Full Text] [Related]
8. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.
Murewanhema G; Malisheni M; Takah NF
Pan Afr Med J; 2021; 38():308. PubMed ID: 34178226
[TBL] [Abstract][Full Text] [Related]
10. Social Support Networks Among Young Men and Transgender Women of Color Receiving HIV Pre-Exposure Prophylaxis.
Wood S; Dowshen N; Bauermeister JA; Lalley-Chareczko L; Franklin J; Petsis D; Swyryn M; Barnett K; Weissman GE; Koenig HC; Gross R
J Adolesc Health; 2020 Mar; 66(3):268-274. PubMed ID: 31672523
[TBL] [Abstract][Full Text] [Related]
11. Meta-synthesis of Qualitative Research of Pre-exposure Prophylaxis (PrEP) Adherence Among Men Who Have Sex With Men (MSM).
Ching SZ; Wong LP; Said MAB; Lim SH
AIDS Educ Prev; 2020 Oct; 32(5):416-431. PubMed ID: 33112675
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women.
Thomson KA; Baeten JM; Mugo NR; Bekker LG; Celum CL; Heffron R
Curr Opin HIV AIDS; 2016 Jan; 11(1):18-26. PubMed ID: 26417954
[TBL] [Abstract][Full Text] [Related]
13. Pre-exposure Prophylaxis Uptake, Adherence, and Persistence: A Narrative Review of Interventions in the U.S.
Garrison LE; Haberer JE
Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S73-S86. PubMed ID: 34686294
[TBL] [Abstract][Full Text] [Related]
14. Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM).
Owens C; Hubach RD; Lester JN; Williams D; Voorheis E; Reece M; Dodge B
AIDS Care; 2020 Dec; 32(12):1581-1588. PubMed ID: 32338061
[TBL] [Abstract][Full Text] [Related]
15. Identifying Best Practices for Increasing HIV Pre-exposure Prophylaxis (PrEP) Use and Persistence in the United States: A Systematic Review.
Kamitani E; Higa DH; Crepaz N; Wichser M; Mullins MM;
AIDS Behav; 2024 Jul; 28(7):2340-2349. PubMed ID: 38743381
[TBL] [Abstract][Full Text] [Related]
16. Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.
Gengiah TN; Moosa A; Naidoo A; Mansoor LE
Int J Clin Pharm; 2014 Feb; 36(1):70-85. PubMed ID: 24129582
[TBL] [Abstract][Full Text] [Related]
17. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
[TBL] [Abstract][Full Text] [Related]
18. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
[TBL] [Abstract][Full Text] [Related]
19. HPTN 083-02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study.
Psaros C; Goodman GR; Lee JS; Rice W; Kelley CF; Oyedele T; Coelho LE; Phanuphak N; Singh Y; Middelkoop K; Griffith S; McCauley M; Rooney J; Rinehart AR; Clark J; Go V; Sugarman J; Fields SD; Adeyeye A; Grinsztejn B; Landovitz RJ; Safren SA;
J Int AIDS Soc; 2024 May; 27(5):e26252. PubMed ID: 38783534
[TBL] [Abstract][Full Text] [Related]
20. Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China.
Hu Y; Zhong XN; Peng B; Zhang Y; Liang H; Dai JH; Zhang JY; Huang AL
BMC Infect Dis; 2018 Nov; 18(1):575. PubMed ID: 30442106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
